RecruitingPhase 2NCT07589595
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
Carlsbad, CA · Irvine, CA · La Jolla, CA · +39 more sites
2 recruiting alzheimer's disease studies with a site in Carlsbad, CA.
Sponsor: Eli Lilly and Company
Carlsbad, CA · Irvine, CA · La Jolla, CA · +39 more sites
Sponsor: The Neurology Center of Southern California
Carlsbad, CA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.